- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06541210
Het bouwen van gemeenschapswoonlaboratoria in zwarte gemeenschappen om de gelijkheid van de prostaatgezondheid te bevorderen en de verschillen in prostaatkanker bij zwarte mannen te verminderen (CoLLab)
Het bouwen van Community Living Labs (CoLLab) in zwarte gemeenschappen met als doel de gelijkheid van de prostaatgezondheid te bevorderen en de verschillen in prostaatkanker bij zwarte mannen te verminderen
This clinical trial the possibility of establishing a Community Living Labs (CoLLab) Learning Health System to facilitate access to prostate health Risk, Education, and Assessment in the Community with Help (REACH) services in Black men and compares the impact to American Legion Posts with no CoLLab set up at the individual and community levels. Cancer is the second leading cause of death for Black men and Black men are less likely to receive prostate cancer screening. CoLLab Learning Health System utilizes community health workers (CHW) that are well-trained to form a bridge between communities and clinicians. In fact, Black men who work with CHW's typically have better access to health services, gain knowledge about cancer, cancer prevention, treatment and may have better overall health outcomes. Establishing a CoLLab Learning Health System at American Legion Posts may improve access to clinical trials and prostate cancer services in Black men.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
PRIMARY OBJECTIVES:
I. Co-create real-life user centric CoLLab Learning Health System at three American Legion Posts, compared to an American Legion Post with no CoLLab set-up. American Legion Post 197 will serve as the hub and Post 244 and Post 194 as the spokes.
II. Assess and evaluate the impact of the CoLLab Learning Health Systems compared to the comparison Post at the individual and community levels.
III. Explore the feasibility of replicating the CoLLab Learning Health System in Black communities nationally.
OUTLINE:
Participants access CoLLab Learning Health System to use any of the services at least twice monthly for up to 1 year.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Clinical Trials Referral Office
- Telefoonnummer: 855-776-0015
- E-mail: mayocliniccancerstudies@mayo.edu
Studie Contact Back-up
- Naam: Quincy Wimberly
- Telefoonnummer: 904-953-0974
- E-mail: Wimberly.Quincy@mayo.edu
Studie Locaties
-
-
Florida
-
Jacksonville, Florida, Verenigde Staten, 32224-9980
- Werving
- Mayo Clinic in Florida
-
Contact:
- Clinical Trials Referral Office
- Telefoonnummer: 855-776-0015
- E-mail: mayocliniccancerstudies@mayo.edu
-
Hoofdonderzoeker:
- Folakemi T. Odedina, Ph.D.
-
Contact:
- Quincy Wimberly
- Telefoonnummer: 904-953-0974
- E-mail: Wimberly.Quincy@mayo.edu
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
-
AIMS 1 AND 3: Participants must be one of the following key personnel:
- Community PI (n=1),
- CoLLab Program Manager (n=1)
- CoLLab Site Managers (n=3)
- CoLLab CAB members (n=21)
- 2 Community Health Workers (CHWs) per Post site (n=6)
-
AIMS 1 AND 3: Between the ages of 21 and 80.
-
AIMS 1 AND 3: Able to complete the survey in English.
-
AIMS 1 AND 3: Reside in the Jacksonville, FL and/or surrounding counties.
-
AIMS 1 AND 3: Willing and able to consent to the study.
-
AIM 2: Black adult of any gender.
-
AIM 2: Must be between the ages of 30 and 80.
-
AIM 2: Able to speak English.
-
AIM 2: Reside in the Jacksonville, FL and/or surrounding counties.
-
AIM 2: Willing and able to consent to the study.
Exclusion Criteria:
- AIMS 1 AND 3: Younger than 21years or older than 80 years.
- AIMS 1 AND 3: Not a resident of NE Florida. Unwilling or unable to consent to the study.
- AIM 2: Younger than 30 years or older than 80 years.
- AIM 2: Not a resident of NE Florida.
- AIM 2: Unwilling or unable to consent to the study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Health services research (CoLLab Learning Health System)
Participants access CoLLab Learning Health System to use any of the services at least twice monthly for up to 1 year. |
Ancillary studies Access CoLLab Learning Health System to use any of the services
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Create real-life user centric CoLLab Learning Health System (program production)
Tijdsspanne: Up to 12 months
|
Qualitative data collection will be employed during a town hall meeting with the CoLLab Community Advisory Board (CAB) to ensure that we get unbiased and objective feedback from participants. |
Up to 12 months
|
|
Impact of the CoLLab Learning Health Systems
Tijdsspanne: Baseline; up to 12 months
|
Will be assessed using pre-test and post-test survey scores from a Prostate Health Resources Questionnaire, which consists of 6 multiple choice questions, 8 true/false/don't know questions, 13 questions answered on a 5-point scale (e.g., very favorable to unfavorable or strongly agree to strongly disagree), and 20 yes/no questions. |
Baseline; up to 12 months
|
|
Feasibility of Replication - cost analysis
Tijdsspanne: Up to 24 months
|
Will be assessed using cost analysis of direct and indirect costs. |
Up to 24 months
|
|
Feasibility of Replication - qualitative
Tijdsspanne: Up to 24 months
|
Will be assessed qualitatively based on interviews of key personnel and users |
Up to 24 months
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Folakemi T. Odedina, Ph.D., Mayo Clinic
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Urogenitale ziekten
- Genitale ziekten
- Genitale neoplasmata, mannelijk
- Urogenitale neoplasmata
- Neoplasmata per site
- Neoplasmata
- Genitale ziekten, man
- Prostaat Ziekten
- Mannelijke urogenitale ziekten
- Prostaatneoplasmata
- Gezondheidsdiensten
- Gezondheidszorgfaciliteiten personeel en diensten
- Community Health Services
Andere studie-ID-nummers
- 23-007988
- 23-007988 (Andere identificatie: Mayo Clinic in Florida)
- NCI-2024-06410 (Register-ID: CTRP (Clinical Trial Reporting Program))
- CoLLab (Andere identificatie: Mayo Clinic)
- W81XWH-22-PCRP-IDA (Ander subsidie-/financieringsnummer: Department of Defense)
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .